121 related articles for article (PubMed ID: 35443507)
1. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.
P P; Krishnamurthy V; Kumar TA
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443507
[TBL] [Abstract][Full Text] [Related]
2. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID-19 infection.
Krishnamurthy V; Sujatha KJ; Kumar TA; Phaniraj P; Shankar T; Raj MP
Ann Afr Med; 2022; 21(3):278-282. PubMed ID: 36204916
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
[TBL] [Abstract][Full Text] [Related]
4. The role of eosinophil as a diagnostic, differential, and prognostic marker for Covid-19 during pregnancy: Case-control study from tertiary center.
Atalay A; Sinaci S; Besimoglu B; Ozkavak O; Kaya E; Kara O; Sahin D
J Obstet Gynaecol Res; 2023 Aug; 49(8):2063-2072. PubMed ID: 37309016
[TBL] [Abstract][Full Text] [Related]
5. Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study.
Wang X; Dian Y; Zhou Q; Deng G; Wei R; Zeng F
Front Immunol; 2023; 14():1320973. PubMed ID: 38162638
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.
Eijmael M; Janssens N; le Cessie S; van Dooren Y; Koster T; Karim F
Infection; 2021 Dec; 49(6):1325-1329. PubMed ID: 34625911
[TBL] [Abstract][Full Text] [Related]
7. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
8. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
[TBL] [Abstract][Full Text] [Related]
9. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
Cazzaniga M; Fumagalli LAM; D'angelo L; Cerino M; Bonfanti G; Fumagalli RM; Schiavo G; Lorini C; Lainu E; Terragni S; Chiarelli M; Scarazzati C; Bonato C; Zago M
Int J Clin Pract; 2021 Jul; 75(7):e14047. PubMed ID: 33497517
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil count (EC) as a diagnostic and prognostic marker for infection in the internal medicine department setting.
Karakonstantis S; Gryllou N; Papazoglou G; Lydakis C
Rom J Intern Med; 2019 Jun; 57(2):166-174. PubMed ID: 30517081
[TBL] [Abstract][Full Text] [Related]
11. Study of early warning efficiency of different laboratory markers in predicting progression of disease in COVID-19.
Krishnamurthy V; Suhail KM; Aslam SSM; Raj MP; Patil P; Phaniraj P
Ann Afr Med; 2022; 21(4):371-376. PubMed ID: 36412337
[TBL] [Abstract][Full Text] [Related]
12. Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients Presenting with Acute Myocardial Infarction.
Alkhalil M; Kearney A; Hegarty M; Stewart C; Devlin P; Owens CG; Spence MS
Am J Med; 2019 Dec; 132(12):e827-e834. PubMed ID: 31152721
[TBL] [Abstract][Full Text] [Related]
13. Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarker.
Partouche B; Pepin M; de Farcy PM; Kahn JE; Sawczynski B; Lechowski L; Teillet L; Barbot F; Herr M; Davido B
BMC Geriatr; 2021 Oct; 21(1):557. PubMed ID: 34649512
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients.
Gambichler T; Schuleit N; Susok L; Becker JC; Scheel CH; Torres-Reyes C; Overheu O; Reinacher-Schick A; Schmidt W
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766326
[TBL] [Abstract][Full Text] [Related]
15. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.
Anurag A; Jha PK; Kumar A
Diabetes Metab Syndr; 2020; 14(6):2099-2102. PubMed ID: 33160224
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.
Liu J; Li H; Luo M; Liu J; Wu L; Lin X; Li R; Wang Z; Zhong H; Zheng W; Zhou Y; Jiang D; Tan X; Zhou Z; Peng H; Zhang G
PLoS One; 2020; 15(11):e0241659. PubMed ID: 33206680
[TBL] [Abstract][Full Text] [Related]
17. Eosinopenia as a diagnostic marker of bloodstream infection in a general internal medicine setting: a cohort study.
Hirosawa T; Harada Y; Morinaga K; Takase H; Nin M; Shimizu T
BMC Infect Dis; 2020 Jan; 20(1):85. PubMed ID: 32000694
[TBL] [Abstract][Full Text] [Related]
18. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study.
Li Q; Ding X; Xia G; Chen HG; Chen F; Geng Z; Xu L; Lei S; Pan A; Wang L; Wang Z
EClinicalMedicine; 2020 Jun; 23():100375. PubMed ID: 32368728
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
[TBL] [Abstract][Full Text] [Related]
20. A biological profile for diagnosis and outcome of COVID-19 patients.
Khourssaji M; Chapelle V; Evenepoel A; Belkhir L; Yombi JC; van Dievoet MA; Saussoy P; Coche E; Fillée C; Constantinescu SN; Rodriguez-Villalobos H; Defour JP; Gruson D
Clin Chem Lab Med; 2020 Oct; 58(12):2141-2150. PubMed ID: 33064667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
